GGrantIndex
← Leaderboards

Larry S. Sherman

Oregon Health & Science University

Google Scholar ↗PubMed ↗ORCID ↗
$10,263,725
Attributed
$11,318,458
Total exposure
67
Grants
57
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY2005–25
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,318,458 · 67

By mechanism

P51$3,400,501 · 56
R24$3,315,801 · 2
R01$3,199,690 · 4
R21$1,236,866 · 3
R03$143,100 · 1
R13$22,500 · 1

Top collaborators

Others in their field

Top investigators on “Resources”

Research focus

ResourcesFundingSourceGrantUnited States National Institutes Of HealthResearch PersonnelInstitutionComputer Retrieval Of Information On Scientific Projects DatabaseHyaluronanPrimatesCellsPreventLesionCd44 GeneWhite MatterGenesLinkGlycosaminoglycansOligodendrogliaStem CellsAffectNerve Stem CellAdultExtracellular Matrix

Grant awards (86)

A National NHP Embryo Resource of Human Genetic Disease Models$617,679
R24 · FY2025 · OD · contact PI
Regulation of brain vascular endothelial cell ferroptosis by hyaluronan$471,885
R21 · FY2025 · AG · contact PI
A National NHP Embryo Resource of Human Genetic Disease Models$672,595
R24 · FY2024 · OD · contact PI
A National NHP Embryo Resource of Human Genetic Disease Models$819,192
R24 · FY2023 · OD · contact PI
Hyaluron as a regulator of chemotherapy-induced changes in neurogenesis$184,075
R21 · FY2021 · CA · contact PI
A non-human primate resource for pre-clinical studies of neurodegenerative disease$444,976
R24 · FY2020 · NS · contact PI
Hyaluron as a regulator of chemotherapy-induced changes in neurogenesis$184,075
R21 · FY2020 · CA · contact PI
A non-human primate resource for pre-clinical studies of neurodegenerative disease$346,259
R24 · FY2019 · NS · contact PI
Hyaluron as a regulator of chemotherapy-induced changes in neurogenesis$222,237
R21 · FY2019 · CA · contact PI
A non-human primate resource for pre-clinical studies of neurodegenerative disease$415,100
R24 · FY2018 · NS · contact PI
Children's Tumor Foundation 2017 Neurofibromatosis (NF) Conference$22,500
R13 · FY2017 · NS · contact PI
WHITE MATTER DAMAGE IN AGE-RELATED COGNITIVE DECLINE$58,239
P51 · FY2011 · RR · contact PI
THERAPEUTIC REMYELINATION STRATEGIES IN A NOVEL MODEL OF MS$58,239
P51 · FY2011 · RR · contact PI
NOVEL HYALURONIDASE INHIBITORS FOR THE PROMOTION OF REMYELINATION$58,239
P51 · FY2011 · RR · contact PI
ROLE OF EXTRACELLULAR MATRIX IN HYPOXIC-ISCHEMIC PERINATAL WHITE MATTER INJURY$43,647
P51 · FY2011 · RR · contact PI
COLLABORATIVE MS RESEARCH CENTER AWARD$36,286
P51 · FY2011 · RR · contact PI
EVALUTATION OF HUMAN STEM CELL ENGRAFTMENT TO SHIVERER MICE$36,286
P51 · FY2011 · RR · contact PI
EFFECTS OF HYALURONAN ON NEURAL STEM CELL HOMING AND DIFFERENTIATION$36,286
P51 · FY2011 · RR · contact PI
EFFECTS OF ETHANOL EXPOSURE ON HYALURONAN-MEDIATED ADULT NEUROGENESIS$36,286
P51 · FY2011 · RR · contact PI
TARGETING NEUROTROPHIC FACTOR RECEPTORS TO BLOCK PAIN IN SCHWANNOMATOSIS$36,286
P51 · FY2011 · RR · contact PI
ROLE OF HYALURONAN INHIBITORS IN ETHANOL-INDUCED CHANGES IN NEUROGENESIS$18,208
P51 · FY2011 · RR · contact PI
THERAPEUTIC REMYELINATION STRATEGIES IN A NOVEL MODEL OF MS$95,066
P51 · FY2010 · RR · contact PI
WHITE MATTER DAMAGE IN AGE-RELATED COGNITIVE DECLINE$76,080
P51 · FY2010 · RR · contact PI
EFFECTS OF HYALURONAN ON NEURAL STEM CELL HOMING AND DIFFERENTIATION$76,080
P51 · FY2010 · RR · contact PI
ROLE OF EXTRACELLULAR MATRIX IN HYPOXIC-ISCHEMIC PERINATAL WHITE MATTER INJURY$57,095
P51 · FY2010 · RR · contact PI
TARGETING HYALURONIDASES AS A STRATEGY TO REVERSE REMYELINATION FAILURE$57,095
P51 · FY2010 · RR · contact PI
EVALUATION OF THE SAFETY & EFFICACY OF AN IMPLANTED BIODEGRADABLE SCAFFOLD$47,603
P51 · FY2010 · RR · contact PI
ROLE OF SNF5 IN SCHWANN CELL TUMORIGENENSIS$47,603
P51 · FY2010 · RR · contact PI
ROLE OF HYALURONAN IN INHIBITION OF REMYELINATION$47,603
P51 · FY2010 · RR · contact PI
ROLE OF SW1/SNF FACTORS IN SCHWANNOMATOSIS ASSOCIATED PAIN$47,603
P51 · FY2010 · RR · contact PI
VASCULAR ENDOTHELIUM-DERIVED FACTORS IN STURGE-WEBER SYNDROME HYPERMYELINATION$47,603
P51 · FY2010 · RR · contact PI
EFFECTS OF HYALURONAN ON NEURAL STEM CELL HOMING AND DIFFERENTIATION$80,343
P51 · FY2009 · RR · contact PI
PHYTOESTROGENS AS AN ALTERNATIVE TREATMENT FOR MS$80,343
P51 · FY2009 · RR · contact PI
ROLE OF HYALURONAN IN SCHWANNOMA GROWTH$80,343
P51 · FY2009 · RR · contact PI
ROLE OF EXTRACELLULAR MATRIX IN HYPOXIC-ISCHEMIC PERINATAL WHITE MATTER INJURY$60,393
P51 · FY2009 · RR · contact PI
A LENTIVIRAL-RNAI STRATEGY TO REDUCE HYALURONAN IN DEMYELINATING LESIONS$60,393
P51 · FY2009 · RR · contact PI
ROLE OF BRG1 IN NEURAL STEM CELL DIFFERENTIATION$50,214
P51 · FY2009 · RR · contact PI
ROLE OF SNF5 IN SCHWANN CELL TUMORIGENENSIS$50,214
P51 · FY2009 · RR · contact PI
COLLABORATIVE MULTIPLE SCLEROSIS RESEARCH CENTER AWARD$50,214
P51 · FY2009 · RR · contact PI
VASCULAR ENDOTHELIUM-DERIVED FACTORS IN STURGE-WEBER SYNDROME HYPERMYELINATION$50,214
P51 · FY2009 · RR · contact PI
ROLE OF HYALURONAN IN INHIBITION OF REMYELINATION$34,471
P51 · FY2009 · RR · contact PI
Effects of hyaluronan on neural stem cell homing and differentiation$317,370
R01 · FY2008 · NS · contact PI
PHYTOESTROGENS AS AN ALTERNATIVE TREATMENT FOR MS$55,512
P51 · FY2008 · RR · contact PI
ROLE OF HYALURONAN IN SCHWANNOMA GROWTH$55,512
P51 · FY2008 · RR · contact PI
EFFECTS OF HYALURONAN ON NEURAL STEM CELL HOMING AND DIFFERENTIATION$55,512
P51 · FY2008 · RR · contact PI
ROLE OF HYALURONAN IN INHIBITION OF REMYELINATION$55,512
P51 · FY2008 · RR · contact PI
HYALURONAN AS A STEM CELL NICHE SIGNAL$27,704
P51 · FY2008 · RR · contact PI
ROLE OF BRG1 IN NEURAL STEM CELL DIFFERENTIATION$27,704
P51 · FY2008 · RR · contact PI
ROLE OF EXTRACELLULAR MATRIX IN HYPOXIC-ISCHEMIC PERINATAL WHITE MATTER INJURY$27,704
P51 · FY2008 · RR · contact PI
ADULT NEURAL STEM CELLS AS VECTORS TO TREAT REMYELINATION FAILURE$27,704
P51 · FY2008 · RR · contact PI
A LENTIVIRAL-RNAI STRATEGY TO REDUCE HYALURONAN IN DEMYELINATING LESIONS$27,704
P51 · FY2008 · RR · contact PI
Effects of hyaluronan on neural stem cell homing and differentiation$317,518
R01 · FY2007 · NS · contact PI
EFFECTS OF HYALURONAN ON NEURAL STEM CELL HOMING AND DIFFERENTIATION$75,851
P51 · FY2007 · RR · contact PI
PHYTOESTROGENS AS AN ALTERNATIVE TREATMENT FOR MS$75,851
P51 · FY2007 · RR · contact PI
ROLE OF BRG1 IN NEURAL STEM CELL DIFFERENTIATION$75,850
P51 · FY2007 · RR · contact PI
ROLE OF HYALURONAN IN INHIBITION OF REMYELINATION$75,850
P51 · FY2007 · RR · contact PI
ROLE OF EXTRACELLULAR MATRIX IN HYPOXIC-ISCHEMIC PERINATAL WHITE MATTER INJURY$75,850
P51 · FY2007 · RR · contact PI
C-MET INDUCTION IN THE HIPPOCAMPUS OF FN1-NULL MICE$75,850
P51 · FY2007 · RR · contact PI
HYALURONATE IN AGING-RELATED GLIOSIS AND DEMYELINATION$14,673
P51 · FY2007 · RR · contact PI
ROLE OF CD44-DERIVED A-BETA-LIKE PEPTIDE IN OLIGODENDROCYTES$14,673
P51 · FY2007 · RR · contact PI
Effects of hyaluronan on neural stem cell homing and differentiation$325,333
R01 · FY2006 · NS · contact PI
Phytoestrogens as an alternative treatment for MS$194,636
R01 · FY2006 · AT · contact PI
ROLE OF BRG1 IN NEURAL STEM CELL DIFFERENTIATION$76,828
P51 · FY2006 · RR · contact PI
ROLE OF CD44-DERIVED A-BETA-LIKE PEPTIDE IN OLIGODENDROCYTES$76,828
P51 · FY2006 · RR · contact PI
HYALURONATE IN AGING-RELATED GLIOSIS AND DEMYELINATION$76,828
P51 · FY2006 · RR · contact PI
Suppression of EAE by placentally derived glycoprotein$174,594
R21 · FY2005 · NS
ROLE OF CD44-DERIVED A-BETA-LIKE PEPTIDE IN OLIGODENDROCYTES$75,569
P51 · FY2005 · RR
ROLE OF HYALURONAN IN INHIBITION OF REMYELINATION$74,664
P51 · FY2005 · RR
ROLE OF CD44 IN PERIPHERAL NERVE DEVELOPMENT AND INJURY$74,664
P51 · FY2005 · RR
HYALURONATE IN AGING-RELATED GLIOSIS AND DEMYELINATION$74,664
P51 · FY2005 · RR
Hyaluronate in aging-related gliosis and demyelination$71,550
R03 · FY2005 · AG
ROLE OF HYALURONATE IN GLIOSIS$82,173
P51 · FY2004 · RR
ROLE OF HYALURONAN IN INHIBITION OF REMYELINATION$82,173
P51 · FY2004 · RR
A TRANSGENIC MOUSE MODEL FOR PROGRESSIVE DEMYELINATION$82,173
P51 · FY2004 · RR
ROLE OF CD44 IN PERIPHERAL NERVE DEVELOPMENT AND INJURY$82,173
P51 · FY2004 · RR
HYALURONATE IN AGING-RELATED GLIOSIS AND DEMYELINATION$82,173
P51 · FY2004 · RR
Hyaluronate in aging-related gliosis and demyelination$71,550
R03 · FY2004 · AG
ROLE OF CD44 IN PERIPHERAL NERVE DEVELOPMENT AND INJURY$24,944
R01 · FY2004 · NS
ROLE OF CD44 IN PERIPHERAL NERVE DEVELOPMENT AND INJURY$329,267
R01 · FY2003 · NS
ROLE OF CD44 IN PERIPHERAL NERVE DEVELOPMENT AND INJURY$307,301
R01 · FY2002 · NS
STABILIZATION OF THE CUMULUS ECM AND OVULATION$265,781
R01 · FY2002 · HD
ROLE OF CD44 IN PERIPHERAL NERVE DEVELOPMENT AND INJURY$305,728
R01 · FY2001 · NS
STABILIZATION OF THE CUMULUS ECM AND OVULATION$257,438
R01 · FY2001 · HD
STABILIZATION OF THE CUMULUS ECM AND OVULATION$250,524
R01 · FY2000 · HD
ROLE OF CD44 IN PERIPHERAL NERVE DEVELOPMENT AND INJURY$237,909
R01 · FY2000 · NS
ROLE OF CD44 IN PERIPHERAL NERVE DEVELOPMENT AND INJURY$65,941
R01 · FY2000 · NS